1. Home
  2. SAIL vs RDY Comparison

SAIL vs RDY Comparison

Compare SAIL & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAIL
  • RDY
  • Stock Information
  • Founded
  • SAIL 2005
  • RDY 1984
  • Country
  • SAIL United States
  • RDY India
  • Employees
  • SAIL N/A
  • RDY N/A
  • Industry
  • SAIL
  • RDY Biotechnology: Pharmaceutical Preparations
  • Sector
  • SAIL
  • RDY Health Care
  • Exchange
  • SAIL NYSE
  • RDY Nasdaq
  • Market Cap
  • SAIL 10.4B
  • RDY 12.1B
  • IPO Year
  • SAIL 2025
  • RDY N/A
  • Fundamental
  • Price
  • SAIL $20.62
  • RDY $13.94
  • Analyst Decision
  • SAIL Buy
  • RDY Strong Buy
  • Analyst Count
  • SAIL 13
  • RDY 2
  • Target Price
  • SAIL $26.65
  • RDY $16.95
  • AVG Volume (30 Days)
  • SAIL 2.1M
  • RDY 1.6M
  • Earning Date
  • SAIL 08-19-2025
  • RDY 07-23-2025
  • Dividend Yield
  • SAIL N/A
  • RDY 0.51%
  • EPS Growth
  • SAIL N/A
  • RDY 2.20
  • EPS
  • SAIL N/A
  • RDY 0.79
  • Revenue
  • SAIL $904,423,000.00
  • RDY $3,897,394,052.00
  • Revenue This Year
  • SAIL $21.75
  • RDY $7.61
  • Revenue Next Year
  • SAIL $19.83
  • RDY $1.89
  • P/E Ratio
  • SAIL N/A
  • RDY $17.57
  • Revenue Growth
  • SAIL 63.60
  • RDY 15.86
  • 52 Week Low
  • SAIL $15.05
  • RDY $12.26
  • 52 Week High
  • SAIL $26.35
  • RDY $16.89
  • Technical
  • Relative Strength Index (RSI)
  • SAIL N/A
  • RDY 33.24
  • Support Level
  • SAIL N/A
  • RDY $14.00
  • Resistance Level
  • SAIL N/A
  • RDY $14.86
  • Average True Range (ATR)
  • SAIL 0.00
  • RDY 0.24
  • MACD
  • SAIL 0.00
  • RDY -0.06
  • Stochastic Oscillator
  • SAIL 0.00
  • RDY 9.13

About SAIL SAILPOINT INC

SailPoint Inc delivers solutions to enable comprehensive identity security for the enterprise. The company does this by unifying identity data across systems and identity types, including employee identities, non-employee identities, and machine identities. The SaaS and customer-hosted offerings of the company leverage intelligent analytics to give organizations critical visibility into which identities currently have access to which resources, which identities should have access to those resources, and how that access is being used. Its solutions enable organizations to establish, control, and automate policies that help them define and maintain a robust security posture and achieve regulatory compliance.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: